- Home
- Publications
- Publication Search
- Publication Details
Title
COVID-19
Authors
Keywords
-
Journal
HYPERTENSION
Volume 76, Issue 2, Pages 294-299
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2020-06-01
DOI
10.1161/hypertensionaha.120.15353
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
- (2020) Haibo Zhang et al. INTENSIVE CARE MEDICINE
- Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury
- (2020) Yingxia Liu et al. Science China-Life Sciences
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age
- (2020) Katarzyna Bilinska et al. ACS Chemical Neuroscience
- The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2
- (2020) Liang Chen et al. CARDIOVASCULAR RESEARCH
- Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
- (2020) Alexandra C. Walls et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- COVID-19 and Cardiovascular Disease
- (2020) Kevin J. Clerkin et al. CIRCULATION
- Substituting Angiotensin-(1-7) to Prevent Lung Damage in SARS-CoV-2 Infection?
- (2020) Concepción Peiró et al. CIRCULATION
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- COVID-19 and the Heart
- (2020) Akbarshakh Akhmerov et al. CIRCULATION RESEARCH
- Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
- (2020) Daniel Batlle et al. CLINICAL SCIENCE
- COVID-19, diabetes mellitus and ACE2: The conundrum
- (2020) Rimesh Pal et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
- (2020) Gabriela M Kuster et al. EUROPEAN HEART JOURNAL
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study.
- (2020) Andrea Conversano et al. HYPERTENSION
- Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study
- (2020) Guang Yang et al. HYPERTENSION
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
- (2020) Giacomo Grasselli et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Can angiotensin receptor-blocking drugs perhaps be harmful in the COVID-19 pandemic?
- (2020) Murray Esler et al. JOURNAL OF HYPERTENSION
- Thromboinflammation and the hypercoagulability of COVID‐19
- (2020) Jean M. Connors et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- SARS-CoV-2 and viral sepsis: observations and hypotheses
- (2020) Hui Li et al. LANCET
- Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19
- (2020) Giuseppe Mancia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19
- (2020) Harmony R. Reynolds et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
- (2020) Muthiah Vaduganathan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
- (2020) Meng-Yuan Li et al. Infectious Diseases of Poverty
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Coronavirus Disease 2019 (COVID-19) Infection and Renin Angiotensin System Blockers
- (2020) Chirag Bavishi et al. JAMA Cardiology
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
- (2020) Neil Mehta et al. JAMA Cardiology
- Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
- (2020) Juyi Li et al. JAMA Cardiology
- ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia
- (2020) Felice Rivellese et al. AUTOIMMUNITY REVIEWS
- Renin-Angiotensin System Blockers and the COVID-19 Pandemic
- (2020) A.H. Jan Danser et al. HYPERTENSION
- Angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and coronavirus
- (2020) Paolo Verdecchia et al. JOURNAL OF HYPERTENSION
- Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
- (2020) Mandeep R. Mehra et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
- (2019) Lauren B. Arendse et al. PHARMACOLOGICAL REVIEWS
- Instillation of particulate matter 2.5 induced acute lung injury and attenuated the injury recovery in ACE2 knockout mice
- (2018) Chung-I Lin et al. International Journal of Biological Sciences
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- Angiotensin-(1-7) Inhibits Thrombin-Induced Endothelial Phenotypic Changes and Reactive Oxygen Species Production via NADPH Oxidase 5 Downregulation
- (2017) Wan-Yu Pai et al. Frontiers in Physiology
- Angiotensin-(1–7) inhibits inflammation and oxidative stress to relieve lung injury induced by chronic intermittent hypoxia in rats
- (2016) W. Lu et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- Alternative Roles of STAT3 and MAPK Signaling Pathways in the MMPs Activation and Progression of Lung Injury Induced by Cigarette Smoke Exposure in ACE2 Knockout Mice
- (2016) Yi-Han Hung et al. International Journal of Biological Sciences
- Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation
- (2015) G S Magalhães et al. BRITISH JOURNAL OF PHARMACOLOGY
- Angiotensin-converting enzyme 2/angiotensin-(1–7)/Mas axis prevents lipopolysaccharide–induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF–κB pathways
- (2015) Yingchuan Li et al. Scientific Reports
- From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension
- (2014) Sheila K. Patel et al. Frontiers in Physiology
- Angiotensin-Converting Enzyme 2/Angiotensin-(1-7)/Mas Axis Protects against Lung Fibrosis by Inhibiting the MAPK/NF-κB Pathway
- (2013) Ying Meng et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
- Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation
- (2013) C. Fang et al. BLOOD
- Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases
- (2013) Keiji Kuba et al. CIRCULATION JOURNAL
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Angiotensin-Converting Enzyme 2 in Healthy Human Subjects
- (2013) Manuel Haschke et al. CLINICAL PHARMACOKINETICS
- Angiotensin-(1-7) attenuates lung fibrosis by way of Mas receptor in acute lung injury
- (2013) Qiuhua Chen et al. JOURNAL OF SURGICAL RESEARCH
- Angiotensin-(1-7) inhibits allergic inflammation, via the MAS1 receptor, through suppression of ERK1/2- and NF-κB-dependent pathways
- (2012) Ahmed Z El-Hashim et al. BRITISH JOURNAL OF PHARMACOLOGY
- Regulation of alveolar epithelial cell survival by the ACE-2/angiotensin 1–7/Mas axis
- (2011) Bruce D. Uhal et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Macrophage Polarization by Angiotensin II-Type 1 Receptor Aggravates Renal Injury-Acceleration of Atherosclerosis
- (2011) Suguru Yamamoto et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect
- (2011) Rodrigo Araujo Fraga-Silva et al. Clinics
- Angiotensin-(1-7) decreases LPS-induced inflammatory response in macrophages
- (2011) Laura L. Souza et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Genetic Ace2 Deficiency Accentuates Vascular Inflammation and Atherosclerosis in the ApoE Knockout Mouse
- (2010) Merlin C. Thomas et al. CIRCULATION RESEARCH
- Crystal structure of NL63 respiratory coronavirus receptor-binding domain complexed with its human receptor
- (2009) K. Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides
- (2008) Patricia E. Gallagher et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Unknown
- (2008) Rodrigo Fraga-Silva et al. MOLECULAR MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now